G. Tran

The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota

T. Chatila, S. Mazmanian, J. Round, 2011, Science.

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

R. Xu, Siddharth Singh, B. Sands, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of Accelerated Infliximab Induction on Short‐ and Long‐term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta‐analysis

A. Ananthakrishnan, F. Colizzo, N. Borren, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

B. Sands, C. Siegel, W. Sandborn, 2018 .

Round Commensal of the Human Microbiota The Toll-Like Receptor 2 Pathway Establishes Colonization by a

T. Chatila, S. Mazmanian, J. Round, 2011 .

277 - Comparative Safety Profile of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy for Inflammatory Bowel Disease: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .

OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis

B. Sands, C. Siegel, W. Sandborn, 2018 .

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

C. Siegel, W. Sandborn, E. Loftus, 2018 .

Sa1723 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Crohn's Disease: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .

328 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Ulcerative Colitis: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .